Underneath we present a selection of stocks filtered out by our screen. Overview: ST Pharm Co., Ltd. provides custom manufacturing services for active pharmaceutical ingredients and intermediates in ...
ST Pharm (KQ:237690) Annual Report This summary provides an overview of the most significant critical numbers from each of the ST Pharm financial reports, including the ST Pharm Co Ltd income ...
ST PHARM has expanded its production facility for oligonucleotides, which are used as raw materials for messenger ribonucleic acid (RNA) therapeutics. The company has set a goal of becoming the ...
SEOUL, South Korea, Nov. 20, 2023 /PRNewswire/ -- Nov. 21, 2023 local time, ST Pharm announced 'Rapid Preparedness of Pandemic Vaccine in 100 Days using ST Pharm's own mRNA Platform Technology' at the ...
The contract development and manufacturing organization (CDMO) is currently one of the top three suppliers of oligonucleotide, which is used to produce nucleic acid therapeutics. With its second plant ...
Korean biotechnology firm, ST Pharm, is in talks with Moderna to produce messenger RNA (mRNA) COVID-19 vaccines, sources familiar with the matter told The Korea Times, Tuesday. "ST Pharm is in talks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results